Files

Download poster

Download Poster (705 KB)

Description

Objective

  • The primary objective of this study was to determine if patients maintain viral suppression after switching from TDF to TAF
  • The secondary objective was to assess changes in renal function and serum cholesterol levels

Publication Date

12-4-2019

Keywords

HIV, tenofovir, weight gain, cholesterol, cardiovascular disease

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Comments

Presented at the 2019 American Society of Health-System Pharmacists Midyear Clinical Meeting

A Real World Assessment of the Efficacy and Safety of Switching from TDF to TAF in Treatment Experienced Patients with HIV Infection

Share

COinS